12/1
09:36 am
maia
MAIA Biotechnology Announces Open Market Purchases by CEO and Directors [Yahoo! Finance]
Medium
Report
MAIA Biotechnology Announces Open Market Purchases by CEO and Directors [Yahoo! Finance]
12/1
09:17 am
maia
MAIA Biotechnology Announces Open Market Purchases by CEO and Directors
Medium
Report
MAIA Biotechnology Announces Open Market Purchases by CEO and Directors
11/21
09:01 am
maia
MAIA Biotechnology Highlights Ongoing Momentum of Ateganosine Clinical Program at SITC 2025
Low
Report
MAIA Biotechnology Highlights Ongoing Momentum of Ateganosine Clinical Program at SITC 2025
11/20
09:22 am
maia
MAIA Biotechnology CEO Presents Telomere Targeting Efficacy at Romania's 2025 Smart Diaspora Conference on Oncology Research and Innovation [Yahoo! Finance]
Medium
Report
MAIA Biotechnology CEO Presents Telomere Targeting Efficacy at Romania's 2025 Smart Diaspora Conference on Oncology Research and Innovation [Yahoo! Finance]
11/20
08:47 am
maia
MAIA Biotechnology CEO Presents Telomere Targeting Efficacy at Romania’s 2025 Smart Diaspora Conference on Oncology Research and Innovation
Medium
Report
MAIA Biotechnology CEO Presents Telomere Targeting Efficacy at Romania’s 2025 Smart Diaspora Conference on Oncology Research and Innovation
11/10
08:18 am
maia
Diamond Equity Research Releases Update Note on MAIA Biotechnology, Inc. (NYSE: MAIA) [Yahoo! Finance]
Low
Report
Diamond Equity Research Releases Update Note on MAIA Biotechnology, Inc. (NYSE: MAIA) [Yahoo! Finance]
10/27
10:45 am
maia
MAIA Biotechnology Presents Trial in Progress Poster at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Low
Report
MAIA Biotechnology Presents Trial in Progress Poster at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
10/23
08:36 am
maia
MAIA Biotechnology Details 30-Month Patient Survival in Ongoing Phase 2 Clinical Trial in Non-Small Cell Lung Cancer
Low
Report
MAIA Biotechnology Details 30-Month Patient Survival in Ongoing Phase 2 Clinical Trial in Non-Small Cell Lung Cancer
10/13
04:20 pm
maia
MAIA Biotechnology Announces $736,600 Private Placement
Medium
Report
MAIA Biotechnology Announces $736,600 Private Placement
10/7
03:33 pm
maia
Cancer drug maker takes sudden pivot into crypto [Yahoo! Finance]
Low
Report
Cancer drug maker takes sudden pivot into crypto [Yahoo! Finance]
10/7
09:13 am
maia
MAIA Biotechnology to hold up to 90% of liquid assets in crypto [Seeking Alpha]
Medium
Report
MAIA Biotechnology to hold up to 90% of liquid assets in crypto [Seeking Alpha]
10/7
08:47 am
maia
MAIA Biotechnology to Initiate Digital Asset Treasury Strategy Focused on Top-Tier Crypto Assets
Medium
Report
MAIA Biotechnology to Initiate Digital Asset Treasury Strategy Focused on Top-Tier Crypto Assets
9/29
04:30 pm
maia
MAIA Biotechnology Announces $2.25 Million Private Placement
Low
Report
MAIA Biotechnology Announces $2.25 Million Private Placement
9/24
08:31 am
maia
MAIA Biotechnology Awarded $2.3 Million Grant by National Institutes of Health for THIO-101 Phase 2 Trial of Cancer-Fighting Agent [Yahoo! Finance]
Medium
Report
MAIA Biotechnology Awarded $2.3 Million Grant by National Institutes of Health for THIO-101 Phase 2 Trial of Cancer-Fighting Agent [Yahoo! Finance]
9/24
08:01 am
maia
MAIA Biotechnology Awarded $2.3 Million Grant by National Institutes of Health for THIO-101 Phase 2 Trial of Cancer-Fighting Agent
Low
Report
MAIA Biotechnology Awarded $2.3 Million Grant by National Institutes of Health for THIO-101 Phase 2 Trial of Cancer-Fighting Agent
9/11
09:51 am
maia
MAIA Biotechnology Highlights Positive Efficacy Data from THIO-101 Phase 2 Clinical Trial in Non-Small Cell Lung Cancer [Yahoo! Finance]
Low
Report
MAIA Biotechnology Highlights Positive Efficacy Data from THIO-101 Phase 2 Clinical Trial in Non-Small Cell Lung Cancer [Yahoo! Finance]
9/11
09:27 am
maia
MAIA Biotechnology Highlights Positive Efficacy Data from THIO-101 Phase 2 Clinical Trial in Non-Small Cell Lung Cancer
Medium
Report
MAIA Biotechnology Highlights Positive Efficacy Data from THIO-101 Phase 2 Clinical Trial in Non-Small Cell Lung Cancer
9/5
09:03 am
maia
MAIA Biotechnology Abstract Selected for Poster Presentation at 2025 IASLC World Conference on Lung Cancer
Medium
Report
MAIA Biotechnology Abstract Selected for Poster Presentation at 2025 IASLC World Conference on Lung Cancer